Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.62 USD | +4.02% | +25.43% | -13.30% |
May. 02 | CUREVAC : A missed opportunity | |
Apr. 26 | UBS Cuts CureVac Price Target to $14 From $18, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.30% | 779M | |
+34.46% | 50.85B | |
+0.58% | 42.82B | |
+49.62% | 42.03B | |
-4.96% | 29.55B | |
+10.68% | 26.11B | |
-21.62% | 19.13B | |
+8.85% | 13.05B | |
+26.96% | 12.16B | |
+24.36% | 12.08B |
- Stock Market
- Equities
- CVAC Stock
- News CureVac N.V.
- UBS Cuts CureVac Price Target to $14 From $18, Maintains Buy Rating